ICD-10-CM/PCS MS-DRG v41.1 Definitions Manual
Previous Page [Alt-p] Up a level [Alt-u] Next Page [Alt-n]
MDC 23 Factors influencing health status and other contacts with health services
Assignment of Diagnosis Codes
Page 19 of 26
E0781 S01151D S1017XD S2191XD S31634D S40211D S50852D S60121D S63101D S66114D S75092D S85169D S93114D S99149G T22229D T24392D T374X1D T423X1D T4595XD T508X5D T628X2D T8052XD T85110D Z333 Z759 Z9851
T4595XDAdverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
T4596XAUnderdosing of unspecified primarily systemic and hematological agent, initial encounter
T4596XDUnderdosing of unspecified primarily systemic and hematological agent, subsequent encounter
T4596XSUnderdosing of unspecified primarily systemic and hematological agent, sequela
T460X1DPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
T460X2DPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
T460X3DPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
T460X4DPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
T460X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T460X6AUnderdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T460X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T460X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
T461X1DPoisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
T461X2DPoisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
T461X3DPoisoning by calcium-channel blockers, assault, subsequent encounter
T461X4DPoisoning by calcium-channel blockers, undetermined, subsequent encounter
T461X5DAdverse effect of calcium-channel blockers, subsequent encounter
T461X6AUnderdosing of calcium-channel blockers, initial encounter
T461X6DUnderdosing of calcium-channel blockers, subsequent encounter
T461X6SUnderdosing of calcium-channel blockers, sequela
T462X1DPoisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
T462X2DPoisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
T462X3DPoisoning by other antidysrhythmic drugs, assault, subsequent encounter
T462X4DPoisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
T462X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
T462X6AUnderdosing of other antidysrhythmic drugs, initial encounter
T462X6DUnderdosing of other antidysrhythmic drugs, subsequent encounter
T462X6SUnderdosing of other antidysrhythmic drugs, sequela
T463X1DPoisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
T463X2DPoisoning by coronary vasodilators, intentional self-harm, subsequent encounter
T463X3DPoisoning by coronary vasodilators, assault, subsequent encounter
T463X4DPoisoning by coronary vasodilators, undetermined, subsequent encounter
T463X5DAdverse effect of coronary vasodilators, subsequent encounter
T463X6AUnderdosing of coronary vasodilators, initial encounter
T463X6DUnderdosing of coronary vasodilators, subsequent encounter
T463X6SUnderdosing of coronary vasodilators, sequela
T464X1DPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
T464X2DPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
T464X3DPoisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
T464X4DPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
T464X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
T464X6AUnderdosing of angiotensin-converting-enzyme inhibitors, initial encounter
T464X6DUnderdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
T464X6SUnderdosing of angiotensin-converting-enzyme inhibitors, sequela
T465X1DPoisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
T465X2DPoisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
T465X3DPoisoning by other antihypertensive drugs, assault, subsequent encounter
T465X4DPoisoning by other antihypertensive drugs, undetermined, subsequent encounter
T465X5DAdverse effect of other antihypertensive drugs, subsequent encounter
T465X6AUnderdosing of other antihypertensive drugs, initial encounter
T465X6DUnderdosing of other antihypertensive drugs, subsequent encounter
T465X6SUnderdosing of other antihypertensive drugs, sequela
T466X1DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
T466X2DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
T466X3DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
T466X4DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
T466X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
T466X6AUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T466X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
T466X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T467X1DPoisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
T467X2DPoisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
T467X3DPoisoning by peripheral vasodilators, assault, subsequent encounter
T467X4DPoisoning by peripheral vasodilators, undetermined, subsequent encounter
T467X5DAdverse effect of peripheral vasodilators, subsequent encounter
T467X6AUnderdosing of peripheral vasodilators, initial encounter
T467X6DUnderdosing of peripheral vasodilators, subsequent encounter
T467X6SUnderdosing of peripheral vasodilators, sequela
T468X1DPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
T468X2DPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
T468X3DPoisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
T468X4DPoisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
T468X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
T468X6AUnderdosing of antivaricose drugs, including sclerosing agents, initial encounter
T468X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
T468X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequela
T46901DPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46902DPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46903DPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46904DPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46905DAdverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46906AUnderdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46906DUnderdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46906SUnderdosing of unspecified agents primarily affecting the cardiovascular system, sequela
T46991DPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46992DPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46993DPoisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46994DPoisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46995DAdverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
T46996AUnderdosing of other agents primarily affecting the cardiovascular system, initial encounter
T46996DUnderdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
T46996SUnderdosing of other agents primarily affecting the cardiovascular system, sequela
T470X1DPoisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter
T470X2DPoisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter
T470X3DPoisoning by histamine H2-receptor blockers, assault, subsequent encounter
T470X4DPoisoning by histamine H2-receptor blockers, undetermined, subsequent encounter
T470X5DAdverse effect of histamine H2-receptor blockers, subsequent encounter
T470X6AUnderdosing of histamine H2-receptor blockers, initial encounter
T470X6DUnderdosing of histamine H2-receptor blockers, subsequent encounter
T470X6SUnderdosing of histamine H2-receptor blockers, sequela
T471X1DPoisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter
T471X2DPoisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter
T471X3DPoisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter
T471X4DPoisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter
T471X5DAdverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
T471X6AUnderdosing of other antacids and anti-gastric-secretion drugs, initial encounter
T471X6DUnderdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
T471X6SUnderdosing of other antacids and anti-gastric-secretion drugs, sequela
T472X1DPoisoning by stimulant laxatives, accidental (unintentional), subsequent encounter
T472X2DPoisoning by stimulant laxatives, intentional self-harm, subsequent encounter
T472X3DPoisoning by stimulant laxatives, assault, subsequent encounter
T472X4DPoisoning by stimulant laxatives, undetermined, subsequent encounter
T472X5DAdverse effect of stimulant laxatives, subsequent encounter
T472X6AUnderdosing of stimulant laxatives, initial encounter
T472X6DUnderdosing of stimulant laxatives, subsequent encounter
T472X6SUnderdosing of stimulant laxatives, sequela
T473X1DPoisoning by saline and osmotic laxatives, accidental (unintentional), subsequent encounter
T473X2DPoisoning by saline and osmotic laxatives, intentional self-harm, subsequent encounter
T473X3DPoisoning by saline and osmotic laxatives, assault, subsequent encounter
T473X4DPoisoning by saline and osmotic laxatives, undetermined, subsequent encounter
T473X5DAdverse effect of saline and osmotic laxatives, subsequent encounter
T473X6AUnderdosing of saline and osmotic laxatives, initial encounter
T473X6DUnderdosing of saline and osmotic laxatives, subsequent encounter
T473X6SUnderdosing of saline and osmotic laxatives, sequela
T474X1DPoisoning by other laxatives, accidental (unintentional), subsequent encounter
T474X2DPoisoning by other laxatives, intentional self-harm, subsequent encounter
T474X3DPoisoning by other laxatives, assault, subsequent encounter
T474X4DPoisoning by other laxatives, undetermined, subsequent encounter
T474X5DAdverse effect of other laxatives, subsequent encounter
T474X6AUnderdosing of other laxatives, initial encounter
T474X6DUnderdosing of other laxatives, subsequent encounter
T474X6SUnderdosing of other laxatives, sequela
T475X1DPoisoning by digestants, accidental (unintentional), subsequent encounter
T475X2DPoisoning by digestants, intentional self-harm, subsequent encounter
T475X3DPoisoning by digestants, assault, subsequent encounter
T475X4DPoisoning by digestants, undetermined, subsequent encounter
T475X5DAdverse effect of digestants, subsequent encounter
T475X6AUnderdosing of digestants, initial encounter
T475X6DUnderdosing of digestants, subsequent encounter
T475X6SUnderdosing of digestants, sequela
T476X1DPoisoning by antidiarrheal drugs, accidental (unintentional), subsequent encounter
T476X2DPoisoning by antidiarrheal drugs, intentional self-harm, subsequent encounter
T476X3DPoisoning by antidiarrheal drugs, assault, subsequent encounter
T476X4DPoisoning by antidiarrheal drugs, undetermined, subsequent encounter
T476X5DAdverse effect of antidiarrheal drugs, subsequent encounter
T476X6AUnderdosing of antidiarrheal drugs, initial encounter
T476X6DUnderdosing of antidiarrheal drugs, subsequent encounter
T476X6SUnderdosing of antidiarrheal drugs, sequela
T477X1DPoisoning by emetics, accidental (unintentional), subsequent encounter
T477X2DPoisoning by emetics, intentional self-harm, subsequent encounter
T477X3DPoisoning by emetics, assault, subsequent encounter
T477X4DPoisoning by emetics, undetermined, subsequent encounter
T477X5DAdverse effect of emetics, subsequent encounter
T477X6AUnderdosing of emetics, initial encounter
T477X6DUnderdosing of emetics, subsequent encounter
T477X6SUnderdosing of emetics, sequela
T478X1DPoisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), subsequent encounter
T478X2DPoisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, subsequent encounter
T478X3DPoisoning by other agents primarily affecting gastrointestinal system, assault, subsequent encounter
T478X4DPoisoning by other agents primarily affecting gastrointestinal system, undetermined, subsequent encounter
T478X5DAdverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
T478X6AUnderdosing of other agents primarily affecting gastrointestinal system, initial encounter
T478X6DUnderdosing of other agents primarily affecting gastrointestinal system, subsequent encounter
T478X6SUnderdosing of other agents primarily affecting gastrointestinal system, sequela
T4791XDPoisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), subsequent encounter
T4792XDPoisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, subsequent encounter
T4793XDPoisoning by unspecified agents primarily affecting the gastrointestinal system, assault, subsequent encounter
T4794XDPoisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, subsequent encounter
T4795XDAdverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
T4796XAUnderdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T4796XDUnderdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
T4796XSUnderdosing of unspecified agents primarily affecting the gastrointestinal system, sequela
T480X1DPoisoning by oxytocic drugs, accidental (unintentional), subsequent encounter
T480X2DPoisoning by oxytocic drugs, intentional self-harm, subsequent encounter
T480X3DPoisoning by oxytocic drugs, assault, subsequent encounter
T480X4DPoisoning by oxytocic drugs, undetermined, subsequent encounter
T480X5DAdverse effect of oxytocic drugs, subsequent encounter
T480X6AUnderdosing of oxytocic drugs, initial encounter
T480X6DUnderdosing of oxytocic drugs, subsequent encounter
T480X6SUnderdosing of oxytocic drugs, sequela
T481X1DPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), subsequent encounter
T481X2DPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, subsequent encounter
T481X3DPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, subsequent encounter
T481X4DPoisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, subsequent encounter
T481X5DAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
T481X6AUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T481X6DUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
T481X6SUnderdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48201DPoisoning by unspecified drugs acting on muscles, accidental (unintentional), subsequent encounter
T48202DPoisoning by unspecified drugs acting on muscles, intentional self-harm, subsequent encounter
T48203DPoisoning by unspecified drugs acting on muscles, assault, subsequent encounter
T48204DPoisoning by unspecified drugs acting on muscles, undetermined, subsequent encounter
T48205DAdverse effect of unspecified drugs acting on muscles, subsequent encounter
T48206AUnderdosing of unspecified drugs acting on muscles, initial encounter
T48206DUnderdosing of unspecified drugs acting on muscles, subsequent encounter
T48206SUnderdosing of unspecified drugs acting on muscles, sequela
T48291DPoisoning by other drugs acting on muscles, accidental (unintentional), subsequent encounter
T48292DPoisoning by other drugs acting on muscles, intentional self-harm, subsequent encounter
T48293DPoisoning by other drugs acting on muscles, assault, subsequent encounter
T48294DPoisoning by other drugs acting on muscles, undetermined, subsequent encounter
T48295DAdverse effect of other drugs acting on muscles, subsequent encounter
T48296AUnderdosing of other drugs acting on muscles, initial encounter
T48296DUnderdosing of other drugs acting on muscles, subsequent encounter
T48296SUnderdosing of other drugs acting on muscles, sequela
T483X1DPoisoning by antitussives, accidental (unintentional), subsequent encounter
T483X2DPoisoning by antitussives, intentional self-harm, subsequent encounter
T483X3DPoisoning by antitussives, assault, subsequent encounter
T483X4DPoisoning by antitussives, undetermined, subsequent encounter
T483X5DAdverse effect of antitussives, subsequent encounter
T483X6AUnderdosing of antitussives, initial encounter
T483X6DUnderdosing of antitussives, subsequent encounter
T483X6SUnderdosing of antitussives, sequela
T484X1DPoisoning by expectorants, accidental (unintentional), subsequent encounter
T484X2DPoisoning by expectorants, intentional self-harm, subsequent encounter
T484X3DPoisoning by expectorants, assault, subsequent encounter
T484X4DPoisoning by expectorants, undetermined, subsequent encounter
T484X5DAdverse effect of expectorants, subsequent encounter
T484X6AUnderdosing of expectorants, initial encounter
T484X6DUnderdosing of expectorants, subsequent encounter
T484X6SUnderdosing of expectorants, sequela
T485X1DPoisoning by other anti-common-cold drugs, accidental (unintentional), subsequent encounter
T485X2DPoisoning by other anti-common-cold drugs, intentional self-harm, subsequent encounter
T485X3DPoisoning by other anti-common-cold drugs, assault, subsequent encounter
T485X4DPoisoning by other anti-common-cold drugs, undetermined, subsequent encounter
T485X5DAdverse effect of other anti-common-cold drugs, subsequent encounter
T485X6AUnderdosing of other anti-common-cold drugs, initial encounter
T485X6DUnderdosing of other anti-common-cold drugs, subsequent encounter
T485X6SUnderdosing of other anti-common-cold drugs, sequela
T486X1DPoisoning by antiasthmatics, accidental (unintentional), subsequent encounter
T486X2DPoisoning by antiasthmatics, intentional self-harm, subsequent encounter
T486X3DPoisoning by antiasthmatics, assault, subsequent encounter
T486X4DPoisoning by antiasthmatics, undetermined, subsequent encounter
T486X5DAdverse effect of antiasthmatics, subsequent encounter
T486X6AUnderdosing of antiasthmatics, initial encounter
T486X6DUnderdosing of antiasthmatics, subsequent encounter
T486X6SUnderdosing of antiasthmatics, sequela
T48901DPoisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), subsequent encounter
T48902DPoisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, subsequent encounter
T48903DPoisoning by unspecified agents primarily acting on the respiratory system, assault, subsequent encounter
T48904DPoisoning by unspecified agents primarily acting on the respiratory system, undetermined, subsequent encounter
T48905DAdverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
T48906AUnderdosing of unspecified agents primarily acting on the respiratory system, initial encounter
T48906DUnderdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter
T48906SUnderdosing of unspecified agents primarily acting on the respiratory system, sequela
T48991DPoisoning by other agents primarily acting on the respiratory system, accidental (unintentional), subsequent encounter
T48992DPoisoning by other agents primarily acting on the respiratory system, intentional self-harm, subsequent encounter
T48993DPoisoning by other agents primarily acting on the respiratory system, assault, subsequent encounter
T48994DPoisoning by other agents primarily acting on the respiratory system, undetermined, subsequent encounter
T48995DAdverse effect of other agents primarily acting on the respiratory system, subsequent encounter
T48996AUnderdosing of other agents primarily acting on the respiratory system, initial encounter
T48996DUnderdosing of other agents primarily acting on the respiratory system, subsequent encounter
T48996SUnderdosing of other agents primarily acting on the respiratory system, sequela
T490X1DPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), subsequent encounter
T490X2DPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, subsequent encounter
T490X3DPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, subsequent encounter
T490X4DPoisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, subsequent encounter
T490X5DAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
T490X6AUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T490X6DUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
T490X6SUnderdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T491X1DPoisoning by antipruritics, accidental (unintentional), subsequent encounter
T491X2DPoisoning by antipruritics, intentional self-harm, subsequent encounter
T491X3DPoisoning by antipruritics, assault, subsequent encounter
T491X4DPoisoning by antipruritics, undetermined, subsequent encounter
T491X5DAdverse effect of antipruritics, subsequent encounter
T491X6AUnderdosing of antipruritics, initial encounter
T491X6DUnderdosing of antipruritics, subsequent encounter
T491X6SUnderdosing of antipruritics, sequela
T492X1DPoisoning by local astringents and local detergents, accidental (unintentional), subsequent encounter
T492X2DPoisoning by local astringents and local detergents, intentional self-harm, subsequent encounter
T492X3DPoisoning by local astringents and local detergents, assault, subsequent encounter
T492X4DPoisoning by local astringents and local detergents, undetermined, subsequent encounter
T492X5DAdverse effect of local astringents and local detergents, subsequent encounter
T492X6AUnderdosing of local astringents and local detergents, initial encounter
T492X6DUnderdosing of local astringents and local detergents, subsequent encounter
T492X6SUnderdosing of local astringents and local detergents, sequela
T493X1DPoisoning by emollients, demulcents and protectants, accidental (unintentional), subsequent encounter
T493X2DPoisoning by emollients, demulcents and protectants, intentional self-harm, subsequent encounter
T493X3DPoisoning by emollients, demulcents and protectants, assault, subsequent encounter
T493X4DPoisoning by emollients, demulcents and protectants, undetermined, subsequent encounter
T493X5DAdverse effect of emollients, demulcents and protectants, subsequent encounter
T493X6AUnderdosing of emollients, demulcents and protectants, initial encounter
T493X6DUnderdosing of emollients, demulcents and protectants, subsequent encounter
T493X6SUnderdosing of emollients, demulcents and protectants, sequela
T494X1DPoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), subsequent encounter
T494X2DPoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, subsequent encounter
T494X3DPoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, subsequent encounter
T494X4DPoisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, subsequent encounter
T494X5DAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T494X6AUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T494X6DUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T494X6SUnderdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T495X1DPoisoning by ophthalmological drugs and preparations, accidental (unintentional), subsequent encounter
T495X2DPoisoning by ophthalmological drugs and preparations, intentional self-harm, subsequent encounter
T495X3DPoisoning by ophthalmological drugs and preparations, assault, subsequent encounter
T495X4DPoisoning by ophthalmological drugs and preparations, undetermined, subsequent encounter
T495X5DAdverse effect of ophthalmological drugs and preparations, subsequent encounter
T495X6AUnderdosing of ophthalmological drugs and preparations, initial encounter
T495X6DUnderdosing of ophthalmological drugs and preparations, subsequent encounter
T495X6SUnderdosing of ophthalmological drugs and preparations, sequela
T496X1DPoisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), subsequent encounter
T496X2DPoisoning by otorhinolaryngological drugs and preparations, intentional self-harm, subsequent encounter
T496X3DPoisoning by otorhinolaryngological drugs and preparations, assault, subsequent encounter
T496X4DPoisoning by otorhinolaryngological drugs and preparations, undetermined, subsequent encounter
T496X5DAdverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
T496X6AUnderdosing of otorhinolaryngological drugs and preparations, initial encounter
T496X6DUnderdosing of otorhinolaryngological drugs and preparations, subsequent encounter
T496X6SUnderdosing of otorhinolaryngological drugs and preparations, sequela
T497X1DPoisoning by dental drugs, topically applied, accidental (unintentional), subsequent encounter
T497X2DPoisoning by dental drugs, topically applied, intentional self-harm, subsequent encounter
T497X3DPoisoning by dental drugs, topically applied, assault, subsequent encounter
T497X4DPoisoning by dental drugs, topically applied, undetermined, subsequent encounter
T497X5DAdverse effect of dental drugs, topically applied, subsequent encounter
T497X6AUnderdosing of dental drugs, topically applied, initial encounter
T497X6DUnderdosing of dental drugs, topically applied, subsequent encounter
T497X6SUnderdosing of dental drugs, topically applied, sequela
T498X1DPoisoning by other topical agents, accidental (unintentional), subsequent encounter
T498X2DPoisoning by other topical agents, intentional self-harm, subsequent encounter
T498X3DPoisoning by other topical agents, assault, subsequent encounter
T498X4DPoisoning by other topical agents, undetermined, subsequent encounter
T498X5DAdverse effect of other topical agents, subsequent encounter
T498X6AUnderdosing of other topical agents, initial encounter
T498X6DUnderdosing of other topical agents, subsequent encounter
T498X6SUnderdosing of other topical agents, sequela
T4991XDPoisoning by unspecified topical agent, accidental (unintentional), subsequent encounter
T4992XDPoisoning by unspecified topical agent, intentional self-harm, subsequent encounter
T4993XDPoisoning by unspecified topical agent, assault, subsequent encounter
T4994XDPoisoning by unspecified topical agent, undetermined, subsequent encounter
T4995XDAdverse effect of unspecified topical agent, subsequent encounter
T4996XAUnderdosing of unspecified topical agent, initial encounter
T4996XDUnderdosing of unspecified topical agent, subsequent encounter
T4996XSUnderdosing of unspecified topical agent, sequela
T500X1DPoisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
T500X2DPoisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
T500X3DPoisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
T500X4DPoisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
T500X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounter
T500X6AUnderdosing of mineralocorticoids and their antagonists, initial encounter
T500X6DUnderdosing of mineralocorticoids and their antagonists, subsequent encounter
T500X6SUnderdosing of mineralocorticoids and their antagonists, sequela
T501X1DPoisoning by loop [high-ceiling] diuretics, accidental (unintentional), subsequent encounter
T501X2DPoisoning by loop [high-ceiling] diuretics, intentional self-harm, subsequent encounter
T501X3DPoisoning by loop [high-ceiling] diuretics, assault, subsequent encounter
T501X4DPoisoning by loop [high-ceiling] diuretics, undetermined, subsequent encounter
T501X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounter
T501X6AUnderdosing of loop [high-ceiling] diuretics, initial encounter
T501X6DUnderdosing of loop [high-ceiling] diuretics, subsequent encounter
T501X6SUnderdosing of loop [high-ceiling] diuretics, sequela
T502X1DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), subsequent encounter
T502X2DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, subsequent encounter
T502X3DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, subsequent encounter
T502X4DPoisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, subsequent encounter
T502X5DAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T502X6AUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T502X6DUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T502X6SUnderdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T503X1DPoisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), subsequent encounter
T503X2DPoisoning by electrolytic, caloric and water-balance agents, intentional self-harm, subsequent encounter
T503X3DPoisoning by electrolytic, caloric and water-balance agents, assault, subsequent encounter
T503X4DPoisoning by electrolytic, caloric and water-balance agents, undetermined, subsequent encounter
T503X5DAdverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
T503X6AUnderdosing of electrolytic, caloric and water-balance agents, initial encounter
T503X6DUnderdosing of electrolytic, caloric and water-balance agents, subsequent encounter
T503X6SUnderdosing of electrolytic, caloric and water-balance agents, sequela
T504X1DPoisoning by drugs affecting uric acid metabolism, accidental (unintentional), subsequent encounter
T504X2DPoisoning by drugs affecting uric acid metabolism, intentional self-harm, subsequent encounter
T504X3DPoisoning by drugs affecting uric acid metabolism, assault, subsequent encounter
T504X4DPoisoning by drugs affecting uric acid metabolism, undetermined, subsequent encounter
T504X5DAdverse effect of drugs affecting uric acid metabolism, subsequent encounter
T504X6AUnderdosing of drugs affecting uric acid metabolism, initial encounter
T504X6DUnderdosing of drugs affecting uric acid metabolism, subsequent encounter
T504X6SUnderdosing of drugs affecting uric acid metabolism, sequela
T505X1DPoisoning by appetite depressants, accidental (unintentional), subsequent encounter
T505X2DPoisoning by appetite depressants, intentional self-harm, subsequent encounter
T505X3DPoisoning by appetite depressants, assault, subsequent encounter
T505X4DPoisoning by appetite depressants, undetermined, subsequent encounter
T505X5DAdverse effect of appetite depressants, subsequent encounter
T505X6AUnderdosing of appetite depressants, initial encounter
T505X6DUnderdosing of appetite depressants, subsequent encounter
T505X6SUnderdosing of appetite depressants, sequela
T506X1DPoisoning by antidotes and chelating agents, accidental (unintentional), subsequent encounter
T506X2DPoisoning by antidotes and chelating agents, intentional self-harm, subsequent encounter
T506X3DPoisoning by antidotes and chelating agents, assault, subsequent encounter
T506X4DPoisoning by antidotes and chelating agents, undetermined, subsequent encounter
T506X5DAdverse effect of antidotes and chelating agents, subsequent encounter
T506X6AUnderdosing of antidotes and chelating agents, initial encounter
T506X6DUnderdosing of antidotes and chelating agents, subsequent encounter
T506X6SUnderdosing of antidotes and chelating agents, sequela
T507X1DPoisoning by analeptics and opioid receptor antagonists, accidental (unintentional), subsequent encounter
T507X2DPoisoning by analeptics and opioid receptor antagonists, intentional self-harm, subsequent encounter
T507X3DPoisoning by analeptics and opioid receptor antagonists, assault, subsequent encounter
T507X4DPoisoning by analeptics and opioid receptor antagonists, undetermined, subsequent encounter
T507X5DAdverse effect of analeptics and opioid receptor antagonists, subsequent encounter
T507X6AUnderdosing of analeptics and opioid receptor antagonists, initial encounter
T507X6DUnderdosing of analeptics and opioid receptor antagonists, subsequent encounter
T507X6SUnderdosing of analeptics and opioid receptor antagonists, sequela
T508X1DPoisoning by diagnostic agents, accidental (unintentional), subsequent encounter
T508X2DPoisoning by diagnostic agents, intentional self-harm, subsequent encounter
T508X3DPoisoning by diagnostic agents, assault, subsequent encounter
T508X4DPoisoning by diagnostic agents, undetermined, subsequent encounter



Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244
08 Mar 2024 10:29:37
CMS, code-revision=359, description-revision=1383